Lin Yi-Shu, O'Mahony James F, van Rosmalen Joost
Centre for Health Policy and Management, Trinity College Dublin, 2-4 Foster Place, Dublin, D02 T253, Ireland.
Department of Biostatistics, Erasmus Medical Centre, Rotterdam, The Netherlands.
Pharmacoecon Open. 2023 Jul;7(4):507-523. doi: 10.1007/s41669-023-00414-1. Epub 2023 Jun 1.
Applied cost-effectiveness analysis models are an important tool for assessing health and economic effects of healthcare interventions but are not best suited for illustrating methods. Our objective is to provide a simple, open-source model for the simulation of disease-screening cost-effectiveness for teaching and research purposes. We introduce our model and provide an initial application to examine changes to the efficiency frontier as input parameters vary and to demonstrate face validity. We described a vectorised, discrete-event simulation of screening in R with an Excel interface to define parameters and inspect principal results. An R Shiny app permits dynamic interpretation of simulation outputs. An example with 8161 screening strategies illustrates the cost and effectiveness of varying the disease sojourn time, treatment effectiveness, and test performance characteristics and costs on screening policies. Many of our findings are intuitive and straightforward, such as a reduction in screening costs leading to decreased overall costs and improved cost-effectiveness. Others are less obvious and depend on whether we consider gross outcomes or those net to no screening. For instance, enhanced treatment of symptomatic disease increases gross effectiveness, but reduces the net effectiveness and cost-effectiveness of screening. A lengthening of the preclinical sojourn time has ambiguous effects relative to no screening, as cost-effectiveness improves for some strategies but deteriorates for others. Our simple model offers an accessible platform for methods research and teaching. We hope it will serve as a public good and promote an intuitive understanding of the cost-effectiveness of screening.
应用成本效益分析模型是评估医疗保健干预措施的健康和经济效果的重要工具,但并不最适合用于阐述方法。我们的目标是提供一个简单的开源模型,用于教学和研究目的的疾病筛查成本效益模拟。我们介绍我们的模型,并提供一个初始应用,以检验随着输入参数变化效率前沿的变化,并展示表面效度。我们描述了一个在R中进行筛查的向量化离散事件模拟,带有一个Excel界面来定义参数并检查主要结果。一个R Shiny应用程序允许对模拟输出进行动态解释。一个包含8161种筛查策略的示例说明了改变疾病停留时间、治疗效果以及检测性能特征和成本对筛查政策的成本和效果的影响。我们的许多发现直观易懂,例如筛查成本的降低会导致总体成本下降和成本效益提高。其他发现则不那么明显,并且取决于我们考虑的是总结果还是不进行筛查时的净结果。例如,对有症状疾病的强化治疗会提高总效果,但会降低筛查的净效果和成本效益。相对于不进行筛查,临床前期停留时间的延长具有模糊的影响,因为某些策略的成本效益会提高,而另一些策略的成本效益则会恶化。我们的简单模型为方法研究和教学提供了一个易于使用的平台。我们希望它将作为一项公共利益,并促进对筛查成本效益的直观理解。